Abstract
Four established human breast tumour cell lines with different biologic properties were selected for study and requirements for their clonogenic growth in semisolid cultures were identified. The conventional conditions were modified by factors that enhanced colony formation of 3 or more of these cell lines. The modified culture conditions were then applied to the growth in agar of primary breast tumours. A 5-fold improvement in plating efficiency was observed when cultures of 105 primary tumours grown under these modified conditions were compared to those of 52 tumours grown earlier under conventional conditions, and a 4-fold improvement resulted from the addition of hormones and conditioned medidum in 26 tumours cultured simultaneously under both conditions. The biologic relevance of these clonogens recovered in vitro was substantiated by a 70% concordance of in vitro and in vivo tumour sensitivity to anticancer drugs.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bradley T. R., Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966 Jun;44(3):287–299. doi: 10.1038/icb.1966.28. [DOI] [PubMed] [Google Scholar]
- Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
- Hamburger A., Salmon S. E. Primary bioassay of human myeloma stem cells. J Clin Invest. 1977 Oct;60(4):846–854. doi: 10.1172/JCI108839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hug V., Spitzer G., Drewinko B., Blumenschein G. R. Effect of diethylaminoethyl-dextran on colony formation of human tumor cells in semisolid suspension cultures. Cancer Res. 1983 Jan;43(1):210–213. [PubMed] [Google Scholar]
- Hug V., Thames H., Blumenschein G. R., Spitzer G., Drewinko B. Normalization of in vitro sensitivity testing of human tumor clonogenic cells. Cancer Res. 1984 Mar;44(3):923–928. [PubMed] [Google Scholar]
- Sikic B. I., Taber R. L. Human tumor clonogenic assays. An overview. Cancer Chemother Pharmacol. 1981;6(3):201–203. doi: 10.1007/BF00256971. [DOI] [PubMed] [Google Scholar]
- Sirbasku D. A. Estrogen induction of growth factors specific for hormone-responsive mammary, pituitary, and kidney tumor cells. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3786–3790. doi: 10.1073/pnas.75.8.3786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Soehnlen B., Young L., Liu R. Standard laboratory procedures for in vitro assay of human tumor stem cells. Prog Clin Biol Res. 1980;48:331–338. [PubMed] [Google Scholar]
- Soule H. D., Vazguez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973 Nov;51(5):1409–1416. doi: 10.1093/jnci/51.5.1409. [DOI] [PubMed] [Google Scholar]
- Todaro G. J., Fryling C., De Larco J. E. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5258–5262. doi: 10.1073/pnas.77.9.5258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Von Hoff D. D., Cowan J., Harris G., Reisdorf G. Human tumor cloning: feasibility and clinical correlations. Cancer Chemother Pharmacol. 1981;6(3):265–271. doi: 10.1007/BF00256979. [DOI] [PubMed] [Google Scholar]